Esaú Fernández-Pascual

Mr. Esaú Fernández-Pascual

Urology, Hospital Universitario La Paz, Madrid, Spain
+1
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2019 in International Journal Of Impotence Research
Verified
Journal Article
Closed access
PDF file
PKPramod Krishnappa
Pramod Krishnappa
Esaú Fernández-PascualEsaú Fernández-Pascual
Esaú Fernández-Pascual
JCJoaquin Carballido
Joaquin Carballido
JMJuan Ignacio Martinez-Salamanca
Juan Ignacio Martinez-Salamanca

14 July 2023 in Medicina
Verified
Journal Article
Open access
PDF file
GMGiuseppe Maiolino
Giuseppe Maiolino
Esaú Fernández-PascualEsaú Fernández-Pascual
Esaú Fernández-Pascual
MAMario Alberto Ochoa Arvizo
Mario Alberto Ochoa Arvizo
RVRanjit Vishwakarma
Ranjit Vishwakarma
JMJuan Ignacio Martínez-Salamanca
Juan Ignacio Martínez-Salamanca
Background and Objectives: The relationship between male infertility (MI) and testicular cancer (TC) is bilateral. On one hand, it is well-established that patients diagnosed with TC have a high risk of pre- and post-treatment infertility. On the other hand, the risk of developing TC in male infertile patients is not clearly defined. The objective of this review is to analyze the histopathological, etiological, and epidemiological associations between MI and the risk of developing testicular cancer. This review aims to provide further insights and offer a guide for assessing the risk factors for TC in infertile men. Materials and Methods: A comprehensive literature search was conducted to identify relevant studies discussing the relationship between MI and the risk of developing TC. Results: The incidence rates of germ cell neoplasia in situ (GCNIS) appear to be high in infertile men, particularly in those with low sperm counts. Most epidemiological studies have found a statistically significant risk of developing TC among infertile men compared to the general or fertile male populations. The concept of Testicular Dysgenesis Syndrome provides an explanatory model for the common etiology of MI, TC, cryptorchidism, and hypospadias. Clinical findings such as a history of cryptorchidism could increase the risk of developing TC in infertile men. Scrotal ultrasound evaluation for testis lesions and microlithiasis is important in infertile men. Sperm analysis parameters can be useful in assessing the risk of TC among infertile men. In the future, sperm and serum microRNAs (miRNAs) may be utilized for the non-invasive early diagnosis of TC and GCNIS in infertile men. Conclusions: MI is indeed a risk factor for developing testicular cancer, as demonstrated by various studies. All infertile men should undergo a risk assessment using clinical examination, ultrasound, and semen parameters to evaluate their risk of TC.

12 June 2020 in Cancers
Verified
Journal Article
Open access
PDF file
FCFelipe Counago
Felipe Counago
FLFernando López-Campos
Fernando López-Campos
AGAna Aurora Diaz Gavela
Ana Aurora Diaz Gavela
EAElena Almagro
Elena Almagro
Esaú Fernández-PascualEsaú Fernández-Pascual
Esaú Fernández-Pascual
ECElia del Cerro
Elia del Cerro
There is clinically relevant molecular heterogeneity in prostate cancer (PCa), but this biological diversity has had only a minimal impact on clinical practice. Treatment outcomes in patients with localised PCa are often highly variable, even among patients stratified to the same risk group or disease state based on standard clinical and pathological parameters. In recent years, the development of gene panels has provided valuable data on the differential expression of genes in patients with PCa. Nevertheless, there is an urgent need to identify and validate prognostic and predictive biomarkers that can be applied across clinical scenarios, ranging from localised disease to metastatic castration-resistant PCa. The availability of such tools would allow for precision medicine to finally reach PCa patients. In this review, we evaluate current data on molecular biomarkers for PCa, with an emphasis on the biomarkers and gene panels with the most robust evidence to support their application in routine clinical practice.

1 February 2019 in The Journal of Sexual Medicine
Verified
Journal Article
Closed access
Esaú Fernández-PascualEsaú Fernández-Pascual
Esaú Fernández-Pascual
FGFrancisco Javier Gonzalez-García
Francisco Javier Gonzalez-García
MRMaría Rodríguez-Monsalve
María Rodríguez-Monsalve
JTJorge Turo
Jorge Turo
CMClaudio Martínez-Ballesteros
Claudio Martínez-Ballesteros
Juan Ignacio Martínez-SalamancaJuan Ignacio Martínez-Salamanca
Juan Ignacio Martínez-Salamanca
Introduction: Patients with Peyronie’s disease (PD) and erectile dysfunction (ED) concomitant with shortening or other malformations benefit from prosthesis implantation and penile lengthening procedures. Aim: To evaluate the safety and efficacy of a multi-incisional technique with penile prosthesis implantation with multiple corporeal incisions and collagen grafting for the surgical management of complex cases of PD with ED and severe penile shortening. Methods: From February 2015–May 2018, 43 consecutive patients with complex PD were treated using this technique. Implantation of a penile prosthesis (malleable or inflatable [IPP]) together with multiple relaxing tunica albuginea incisions and grafting with a self-adhesive collagen-fibrin fleece (TachoSil, Baxter Healthcare) was performed in all patients by a single surgeon (J.I.M.S.). Main Outcome Measure: Penile length and curvature correction, operative time, and incidence of postoperative complications were recorded as outcome measures. Functional outcomes were measured with questionnaires (International Index of Erectile Function-5, Erection Hardness Score, modified Erectile Dysfunction Inventory of Treatment Satisfaction questionnaire, PD Questionnaire) before and 3 and 6 months after surgery. Results: With a median follow-up of 21 months (range 10–31), mean postsurgical penile lengthening was 2.5 (range 1–5) cm, with an improvement in the Bother domain of the PD Questionnaire of 4.4 (range 2–5) points. The average operative time was 86.7 and 71.6 minutes for the IPP and malleable penile prosthesis procedure, respectively. No glans ischemia was recorded; however, 1 IPP infection and 1 delayed distal corporeal erosion were recorded. Hematoma or bruising was observed in 23.2% of patients. The modified Erectile Dysfunction Inventory of Treatment Satisfaction questionnaire was completed by 39 (90.7%) patients. Overall, 89.7% would recommend this surgery. Patient satisfaction with straightness and length was 94.9% and 82.1%, respectively. Clinical Implications: The described technique helps restoration of penile length and erectile function in patients with complex PD. Strengths & Limitations: The strength of the study is that it offers a simple, easy-to-apply technique for surgeons to correct shortening and other malformations in patients with ED and complex PD. The study is limited by the small number of patients, the short follow-up period and the performance of the technique by a single high-volume implanter. Conclusion: The implantation of a penile prosthesis (malleable or inflatable) together with multiple incisions of the plaque/tunica albuginea and grafting with a collagen fleece is a safe and efficient treatment for patients with complex PD in addition to ED and significant shortening.

1 November 2020 in Actas Urológicas Españolas
Verified
Journal Article
Closed access
ATA. Leibar Tamayo
A. Leibar Tamayo
EEE. Linares Espinós
E. Linares Espinós
EGE. Ríos González
E. Ríos González
CGC. Trelles Guzmán
C. Trelles Guzmán
Mario Alvarez-MaestroMario Alvarez-Maestro
Mario Alvarez-Maestro
LML. Martinez-Piñeiro
L. Martinez-Piñeiro

18 September 2019 in Sexual Medicine
Verified
Journal Article
Open access
PKPramod Krishnappa
Pramod Krishnappa
Esaú Fernández-PascualEsaú Fernández-Pascual
Esaú Fernández-Pascual
JCJoaquin Carballido
Joaquin Carballido
IMIgnacio Moncada
Ignacio Moncada
ELEnrique Lledo-Garcia
Enrique Lledo-Garcia
JMJuan Ignacio Martinez-Salamanca
Juan Ignacio Martinez-Salamanca
Introduction: Surgical intervention in Peyronie’s disease (PD) should ideally be delayed until the resolution of acute inflammatory phase. Aim: The objective of this review was to highlight the results of penile prosthesis to correct refractory erectile dysfunction (ED) in patients with PD, and the secondary procedures that may be required to correct the penile curvature. Methods: A systematic search on PubMed online database using Preferred Reporting Items for Systematic Reviews and Meta-Analyses recommendations was done using the MeSH terms “Peyronie’s disease” and “erectile dysfunction.” Main Outcome Measure: Success and satisfaction rates of various procedures. Results: The search yielded 324 language-specific (English and Spanish language) articles and 58 articles were retained for final review. The following variables were assessed in different studies: number of patients, types of secondary procedure to correct the curvature, satisfaction rates, and follow-up period. Conclusion: The aim of the surgery in PD should be to achieve a functionally straight penis (<20 degree curvature) with good erection. Patients with refractory ED in PD are candidates for penile prosthesis. Secondary procedures, like manual modeling, plication, plaque incision, or excision grafting, may be required depending on the degree of penile curvature and penile length. In quest for the best graft, TachoSil graft seems to have gained popularity in Europe.